Xeris Biopharma Holdings, Inc., established in 2005 under Delaware law, is an innovative, self-sustaining, growth-driven biopharmaceutical company dedicated to enhancing patients' lives. The company focuses on developing and commercializing clinically meaningful therapies through a diverse portfolio of products. Leveraging its unique strengths, Xeris achieves this by offering three commercialized products alongside proprietary formulation technologies—XeriSol and XeriJect—which enable strategic partnerships and strengthen their pipeline candidates. Company website: http://www.xerispharma.com Address: 180 N. LaSalle Street Suite 1300 Chicago, Illinois 60607

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for XERS via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.